Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized trial of exemestane versus placebo in postmenopausal women at high risk of invasive breast cancer
2008-008167-99Phase 3Active
- Sponsor
- Unicancer
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast adenocarcinoma comparing Exemestane with Placebo (2 arms). Primary endpoint: Incidence of invasive breast cancer. Started Mar 2009; status: active.
02
Drugs
exemestane
03
Conditions
breast adenocarcinoma
Beyond the preview
Go deeper on 2008-008167-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008167-99.